These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Author: Ebenezer IS.
    Journal: Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310.
    Abstract:
    The effects of subcutaneous (s.c.) administration of arginine-8-vasopressin (AVP) were investigated on the electroencephalogram (EEG) of conscious rats. AVP (1 mcg/kg) had no effect on the EEG. However, AVP (5 and 10 mcg/kg) produced significant changes in the spectral power of the EEG in a manner that was consistent with increase in level of arousal. Analogs of AVP which are virtually devoid of vasopressin V1 receptor agonist activity, desglycinamide-9 arginine-8 vasopressin (10 mcg/kg, s.c.) and 1-deamino-8-D arginine-8 vasopressin (10 mcg/kg, s.c.), had no effect on the EEG. Pretreatment with 1-(beta-mercapto-beta,beta-cyclopentamethylene propionic acid)2(O-methyl)tyrosine arginine-8 vasopressin (10 mcg/kg), a vasopressin V1 receptor antagonist, abolished the effects of AVP (10 mcg/kg) on the EEG. As systemically administered AVP cannot cross the blood-brain barrier, the present results indicate that the effects of s.c. AVP on the EEG of conscious rats are mediated by peripheral vasopressin V1 receptors.
    [Abstract] [Full Text] [Related] [New Search]